Elanco Animal Health Incorporated Common Stock earnings per share and revenue
On Nov 05, 2025, ELAN reported earnings of 0.19 USD per share (EPS) for Q3 25, beating the estimate of 0.13 USD, resulting in a 42.96% surprise. Revenue reached 1.14 billion, compared to an expected 1.11 billion, with a 2.11% difference. The market reacted with a -4.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of 0.11 USD, with revenue projected to reach 1.11 billion USD, implying an decrease of -42.11% EPS, and decrease of -1.95% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
DaVita Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$3.18
Actual
$3.39
Surprise
+6.37%
Encompass Health Corporation Common Stock
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.31
Actual
$1.46
Surprise
+11.35%
FAQ
What were Elanco Animal Health Incorporated Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Elanco Animal Health Incorporated Common Stock reported EPS of $0.19, beating estimates by 42.96%, and revenue of $1.14B, 2.11% above expectations.
How did the market react to Elanco Animal Health Incorporated Common Stock's Q3 2025 earnings?
The stock price moved down -4%, changed from $22.50 before the earnings release to $21.60 the day after.
When is Elanco Animal Health Incorporated Common Stock expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Elanco Animal Health Incorporated Common Stock's next earnings report?
Based on 16
analysts, Elanco Animal Health Incorporated Common Stock is expected to report EPS of $0.11 and revenue of $1.11B for Q4 2025.